Chem-Aqua, Inc. Wins Prestigious R&D 100 Award for New Automatic Biofilm Monitoring Technology

Chem-Aqua, a global water treatment solutions provider based in Irving, Texas, has been honored by R&D Magazine as a 2019 winner of the prestigious R&D 100 Award for the development of their new bioDART biofilm monitoring technology. 

The bioDART Biofouling Monitor was developed to overcome the significant challenges associated with biofilm monitoring in industrial cooling water systems.  Often, by the time a biofilm problem is identified, serious and costly damage has already occurred. The bioDART helps solve this problem by providing a predictive, real-time measure of microbiological activity and biofilm control

The bioDART monitor was recognized as a R&D 100 Award winner in acknowledgement of the impact that water system biofilms play in causing corrosion damage, increasing energy use and greenhouse gas emissions, and transmitting disease.Paul J. Heney, Vice President, and Editorial Director for R&D World stated, “These 100 winning products and technologies are the disruptors that will change industries and make the world a better place in the coming years.”

The bioDART monitor was developed by Chem-Aqua’s New Science and Technology group, which is focused on new and better ways to address the serious problems caused by biofilms.

 

Chem-Aqua is the wholly owned water treatment subsidiary of NCH Corporation, which has does business in 50 countries across the globe. Due to the importance of innovation for company growth and stability, NCH Corporation celebrated their 100th anniversary in 2019 with the theme “100 years of innovation.”

 —

For more information, visit www.chemaqua.com or email info@chemaqua.com

Follow us on social media for the latest updates in B2B!

Image

Latest

pcp
PCP Attribution Analysis
May 22, 2025

Dr. Sam Ambewadikar, RVP and Medical Director at Anthem National Accounts, joins Brent to unpack the power of primary care attribution analysis—a tool he helped pioneer to spotlight the clinical and financial impact of members not having an established PCP. Drawing from his background as a practicing pediatrician and claims analytics leader, Dr. Sam shares…

Read More
sydney health
Sydney Health Demo
May 22, 2025

In this episode, Christina Firouztash, Executive Advisor of Digital Solutions at Anthem, gives a dynamic walkthrough of the Sydney Health app—Anthem’s flagship digital member experience. Christina showcases how Sydney delivers personalized, simple, and equitable navigation across benefits, including virtual care, pharmacy, financial transparency, and social services access. From contextual chatbots and ID card access to…

Read More
pharmacy
Pharmacy Part 1
May 22, 2025

In this episode, Brent chats with Katie Brennan, National Sales Director at CarelonRx, about making pharmacy benefits more accessible, consistent, and member-friendly. Katie spotlights Carelon new advanced home delivery model, which brings the pharmacy counter—and the pharmacist—into the member’s home. With fewer retail pharmacies offering extended hours and many patients lacking reliable transportation, CarelonRx is…

Read More
inclusive care
Inclusive Care
May 22, 2025

Sammy Gonzalez, Regional Vice President at Elevance Health, joins Brent for a deeply personal and impactful conversation on health equity and inclusive care. Sammy shares a powerful story of medical misdiagnosis tied to cultural assumptions, underscoring how bias—even unintentional—can hinder care quality. He highlights Elevance’s work to improve diversity in provider networks, enhance cultural competency,…

Read More